OptiBiotix Health shares crash on first-half results
The price of shares in AIM-listed life sciences firm OptiBiotix Health has plunged by 23.97% as losses for the six months ended 30th June widened by 6%.
The price of shares in AIM-listed life sciences firm OptiBiotix Health has plunged by 23.97% as losses for the six months ended 30th June widened by 6%.
FTSE 250 biotechnology outfit PureTech Health has seen its share price drop by 1.11% after it published results for the six months ended 30th June.
Shares in FTSE 100 outsourcer Bunzl advanced 0.25% to 2,038p as pre-tax profits for the six months ended 30th June climbed by 1.6%.
AIM-listed drug development outfit Sareum has seen its share price drop by 11.83% after it lost £1.45 million before tax over the year ended 30th June.
Entertainment One has seen its share price shoot upwards by 34.23% after it entered in to an agreement to sell the business to Hasbro.
The price of shares in Computacenter has risen by 4.29% after the company announced a 20.8% increase in revenues for the six months ended 30th June.
AIM-listed gold miner Hummingbird Resources has seen its share price drop by 0.68% after it published results for the half year ended 30th June.
The price of shares in private healthcare provider NMC Health has risen by 25.81% after its EBITDA climbed by 22.5% during the first half of 2019.
John Laing has seen its share price drop by 6.20% following the publication of a mixed set of results for the six months to 30th June.
AIM-listed software developer Sopheon has seen its share price climb by 5.84% despite revenues and EBITDA dropping for the six months ended 30th June.